Mulpleta is a thrombopoietin receptor agonist for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.

Efficacy

Efficacy

The majority of patients achieved a platelet count ≥50,000/µL

Safety

Safety

Safety profile similar to placebo

Dosing

Dosing

One 3-mg tablet taken once daily with or without food for 7 days

Access

Access

Mulpleta is easy to access